These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 21192858)
21. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine. Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607 [TBL] [Abstract][Full Text] [Related]
22. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers. Desheva YA; Smolonogina TA; Donina SA; Rudenko LG BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924 [TBL] [Abstract][Full Text] [Related]
23. Preexisting antibodies against pandemic 2009 influenza A (H1N1) virus in Taiwan. Chang SC; Chang CM; Huang YC; Chiu CH; Shih SR; Lin TY Clin Infect Dis; 2010 Dec; 51(12):1465-7. PubMed ID: 21082879 [No Abstract] [Full Text] [Related]
24. Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines. Woo JC; Ambrose CS Influenza Other Respir Viruses; 2009 Nov; 3(6):257-9. PubMed ID: 19903206 [No Abstract] [Full Text] [Related]
25. Influenza A(H1N1)pdm09 antibodies after pandemic and trivalent seasonal influenza vaccination as well as natural infection in November 2010 in Hamburg, Germany. Cramer J; Mac T; Hogan B; Stauga S; Eberhardt S; Wichmann O; Mertens T; Burchard G Euro Surveill; 2012 Jan; 17(2):. PubMed ID: 22264864 [TBL] [Abstract][Full Text] [Related]
26. Assessing seasonal vaccine-related cross-protection from 2009 pandemic H1N1 influenza through teacher absenteeism. Yin JK; Wang H; Skinner SR; Salkeld G; Booy R Aust N Z J Public Health; 2011 Aug; 35(4):393-4. PubMed ID: 21806738 [No Abstract] [Full Text] [Related]
27. Low seroprotection against preseasonal influenza local strains in children might predict the upcoming epidemic influenza strains. Su WJ; Shao PL; Liu MT; Liu DP; Huang KC; Chang LY; Lu CY; Wang JR; Shih SR; Huang DT; Chi H; Huang LM Clin Infect Dis; 2010 Jul; 51(2):171-6. PubMed ID: 20528478 [TBL] [Abstract][Full Text] [Related]
28. Aflunov(®): a prepandemic influenza vaccine. Gasparini R; Amicizia D; Lai PL; Panatto D Expert Rev Vaccines; 2012 Feb; 11(2):145-57. PubMed ID: 22309663 [TBL] [Abstract][Full Text] [Related]
29. Epidemiology and Relative Severity of Influenza Subtypes in Singapore in the Post-Pandemic Period from 2009 to 2010. Goh EH; Jiang L; Hsu JP; Tan LWL; Lim WY; Phoon MC; Leo YS; Barr IG; Chow VTK; Lee VJ; Lin C; Lin R; Sadarangani SP; Young B; Chen MI Clin Infect Dis; 2017 Nov; 65(11):1905-1913. PubMed ID: 29028950 [TBL] [Abstract][Full Text] [Related]
30. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City]. You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222 [TBL] [Abstract][Full Text] [Related]
31. Longevity and determinants of protective humoral immunity after pandemic influenza infection. Sridhar S; Begom S; Hoschler K; Bermingham A; Adamson W; Carman W; Riley S; Lalvani A Am J Respir Crit Care Med; 2015 Feb; 191(3):325-32. PubMed ID: 25506631 [TBL] [Abstract][Full Text] [Related]
32. Pandemic (H1N1) 2009 and Hajj Pilgrims who received Predeparture Vaccination, Egypt. Kandeel A; Deming M; Elkreem EA; El-Refay S; Afifi S; Abukela M; Earhart K; El-Sayed N; El-Gabay H Emerg Infect Dis; 2011 Jul; 17(7):1266-8. PubMed ID: 21762583 [TBL] [Abstract][Full Text] [Related]
33. Mechanism for Seasonal Vaccine Effect on Pandemic H1N1 Risk Remains Uncertain. Skowronski DM; Janjua NZ; Hottes TS; De Serres G Clin Infect Dis; 2011 Mar; 52(6):831-2; author reply 832-3. PubMed ID: 21367740 [No Abstract] [Full Text] [Related]
34. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Waalen K; Kilander A; Dudman SG; Krogh GH; Aune T; Hungnes O Euro Surveill; 2010 Aug; 15(31):. PubMed ID: 20738992 [TBL] [Abstract][Full Text] [Related]
35. Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong. Mak GC; Choy PW; Lee WY; Wong AH; Ng KC; Lim W J Med Virol; 2010 Nov; 82(11):1809-15. PubMed ID: 20872705 [TBL] [Abstract][Full Text] [Related]
36. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers. Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721 [TBL] [Abstract][Full Text] [Related]
37. Antibody persistence after Pandemic H1N1 2009 influenza vaccination among healthcare workers in Pune, India. Tandale BV; Pawar SD; Gurav YK; Parkhi SS; Mishra AC Hum Vaccin Immunother; 2013 Jan; 9(1):125-7. PubMed ID: 23047369 [TBL] [Abstract][Full Text] [Related]